The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer's disease.
Neurol Sci
; 45(8): 3599-3609, 2024 Aug.
Article
in En
| MEDLINE
| ID: mdl-38517586
ABSTRACT
Although detailed diagnostic guidelines are available, differentiating dementia with Lewy bodies from Alzheimer's disease is often difficult. 123-I-MIBG cardiac scintigraphy is one of the tools which have been proposed for the diagnostic procedure. The present review is aimed at evaluating the available literature about this topic. Studies assessing the use of this technique to differentiate between the two diseases have been examined and reported. Overall, despite a certain study-to-study variability, the available literature suggests that 123-I-MIBG cardiac scintigraphy is an effective tool in differentiating between the two diseases, with high sensitivity and specificity values. Although the large-scale application of this technique is limited by possible interactions with specific medications and comorbidities, the reported studies are supportive for the usefulness of this technique in clinical practice.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
3-Iodobenzylguanidine
/
Lewy Body Disease
/
Alzheimer Disease
Limits:
Humans
Language:
En
Journal:
Neurol Sci
/
Neurol. sci
/
Neurological sciences
Journal subject:
NEUROLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Italy
Country of publication:
Italy